Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 2
2014 3
2016 1
2018 2
2019 5
2020 5
2021 6
2022 10
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results.
Pereyra-Rodríguez JJ, Herranz P, Ruiz-Villaverde R, Elosua-González M, Galán-Gutiérrez M, Figueras-Nart I, Miquel J, de la Cueva P, Serra-Baldrich E, Munera-Campos M, Melé-Ninot G, Expósito-Serrano V, Perez B, Serrano A, Ortiz de Frutos JF, Armario-Hita JC. Pereyra-Rodríguez JJ, et al. Among authors: armario hita jc. Clin Exp Dermatol. 2023 Aug 25;48(9):991-997. doi: 10.1093/ced/llad153. Clin Exp Dermatol. 2023. PMID: 37098171
Frontal congenital lipoma.
Carranza-Romero C, Armario-Hita JC, Fernandez-Vozmediano JM. Carranza-Romero C, et al. Among authors: armario hita jc. Pediatr Dermatol. 2012 Jul-Aug;29(4):490-4. doi: 10.1111/j.1525-1470.2011.01526.x. Epub 2011 Sep 9. Pediatr Dermatol. 2012. PMID: 21906151
Omalizumab: what benefits should we expect?
Giménez-Arnau A, Velasco M, Armario Hita JC, Labrador-Horrillo M, Silvestre Salvador JF. Giménez-Arnau A, et al. Eur J Dermatol. 2016 Aug 1;26(4):340-4. doi: 10.1684/ejd.2016.2809. Eur J Dermatol. 2016. PMID: 27210073 Free article.
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus.
Pereyra-Rodriguez JJ, Baldrich ES, Ruiz-Villaverde R, Torres EB, De la C Dobao P, Nart IF, Menéndez ÁF, Martin-Santiago A, Miquel JM, Silvestre JF, Armario-Hita JC. Pereyra-Rodriguez JJ, et al. Among authors: armario hita jc. Acta Derm Venereol. 2023 Nov 20;103:adv12314. doi: 10.2340/actadv.v103.12314. Acta Derm Venereol. 2023. PMID: 37982727 Free PMC article. Review.
Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review.
Ayen-Rodríguez A, Pereyra-Rodríguez JJ, Navarro-Triviño FJ, Alcantara-Luna S, Domínguez-Cruz J, Galán-Gutiérrez M, Vilar-Palomo S, Armario-Hita JC, Ruiz-Villaverde R. Ayen-Rodríguez A, et al. Life (Basel). 2022 Jul 30;12(8):1159. doi: 10.3390/life12081159. Life (Basel). 2022. PMID: 36013338 Free PMC article. Review.
Guselkumab: Short-term effectiveness and safety in real clinical practice.
Rodriguez Fernandez-Freire L, Galán-Gutierrez M, Armario-Hita JC, Perez-Gil A, Ruiz-Villaverde R. Rodriguez Fernandez-Freire L, et al. Dermatol Ther. 2020 May;33(3):e13344. doi: 10.1111/dth.13344. Epub 2020 Apr 20. Dermatol Ther. 2020. PMID: 32227659 No abstract available.
38 results